New foam offers hope for kids battling severe eczema
NCT ID NCT07184645
Summary
This study is testing a new foam medication called OPA-15406 to see if it can better control eczema symptoms in children compared to a placebo foam. It will involve about 200 children with moderate eczema, measuring how well their skin clears after 4 weeks of treatment. A smaller part of the study will also test the foam's safety in infants under 2 years old.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS (AD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-••••
Locations
-
Sumire Dermatology Clinic
Tokyo, Japan
Conditions
Explore the condition pages connected to this study.